Efficacy and safety of PEG-rhG-CSF in primary and secondary prevention of chemotherapy-induced neutropenia.

被引:0
|
作者
Zhu, Jun
Li, Huiping
Fan, Zhengfu
Gao, Yunong
Tu, Meifeng
Shao, Bin
Gao, Tian
机构
[1] Peking Univ, Canc Hosp & Inst, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China
[2] Peking Univ, Canc Hosp, Beijing, Peoples R China
[3] Beijing Canc Hosp, Beijing, Peoples R China
[4] Peking Univ, Canc Hosp & Inst, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19051
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Application of pegylated recombinant human granulocyte colony-stimulating factor(PEG-rhG-CSF) for the prevention of neutropenia in triple negative breast cancer patients older than 65 years during adjuvant chemotherapy
    Shuxian Qu
    Jianing Qiu
    Yidan Zhang
    Yongming Liu
    Zhendong Zheng
    OncologyandTranslationalMedicine, 2019, 5 (05) : 218 - 222
  • [42] Efficacy and safety of pegfilgrastim in prophylaxis of chemotherapy-induced neutropenia in breast cancer patients.
    Xia, Wen
    Xu, Fei
    Yuan, Zhongyu
    Xu, Ruilian
    Jiang, Yi
    Wu, Zhiyong
    Lu, Qianyi
    Zheng, Qiufan
    Hong, Ruoxi
    Jiang, Kuikui
    Huang, Jiajia
    An, Xin
    Bi, XiWen
    Hong, Yun
    Pang, Danmei
    Zhang, Anqin
    Wang, Xianming
    Zhang, Qing
    Zhang, Haibo
    Wang, Shusen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Pegfilgrastim in the primary prophylaxis of chemotherapy-induced severe neutropenia
    Olvera Alberto, Serrano
    Fernando, Alban
    Alberto, Villalobos
    Cwilich Raquel, Gerson
    GACETA MEXICANA DE ONCOLOGIA, 2010, 9 (01): : 3 - 10
  • [44] Safety profile of G-CSF in chemotherapy-induced neutropenia: A prospective observational study in Eastern India
    Deb, Uttiya
    Mukhopadhyay, Sandip
    Banerjee, Sanatan
    Biswas, Supreeti
    INDIAN JOURNAL OF CANCER, 2022, 59 (04) : 493 - 498
  • [45] Chemotherapy-induced febrile neutropenia: primary G-CSF prophylaxis indicated during docetaxel cycles
    van Dooijeweert, C.
    van der Wall, E.
    Baas, I. O.
    NETHERLANDS JOURNAL OF MEDICINE, 2019, 77 (09): : 310 - 316
  • [46] Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review
    Blayney, Douglas W.
    Schwartzberg, Lee
    CANCER TREATMENT REVIEWS, 2022, 109
  • [47] Prevention of Chemotherapy-Induced Neutropenia with Pegfilgrastim: Pharmacokinetics and Patient Outcomes
    Yang, Bing-Bing
    Savin, Michael A.
    Green, Michael
    CHEMOTHERAPY, 2012, 58 (05) : 387 - 398
  • [48] Efficacy and safety of aprepitant in the prevention of chemotherapy-induced nausea and vomiting: a pooled analysis
    Jin, Yan
    Wu, Xiaomin
    Guan, Yanmeng
    Gu, Dongying
    Shen, Yue
    Xu, Zhi
    Wei, Xiaowei
    Chen, Jinfei
    SUPPORTIVE CARE IN CANCER, 2012, 20 (08) : 1815 - 1822
  • [49] EFFICACY AND SAFETY OF GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS IN PEDIATRIC-PATIENTS
    LEMERLE, J
    AMARAL, D
    SOUTHALL, DP
    UPWARD, J
    MURDOCH, RD
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (09) : 1081 - 1083
  • [50] Efficacy and safety of HHPG-19K for prophylaxis of chemotherapy-induced neutropenia in patients with lymphoma
    Zheng, M.
    Zhao, J.
    Ma, L.
    Wen, X.
    Wang, J.
    Wu, S.
    Wang, Y.
    Bai, M.
    Zhao, Z.
    Zhang, H.
    Yang, B.
    Zheng, Y.
    Han, W.
    Wang, L.
    Su, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S657 - S657